Simply Wall St.
Assessing Relay Therapeutics (RLAY) Valuation After FDA Breakthrough Therapy Designation For Zovegalisib
📈
AI Sentiment
Highly Positive
9/10
Relay Therapeutics Inc. News
Latest updates and market news for RLAY
2 news
Feb 6 - Feb 12, 2026
Page 1
Motley Fool
Relay Therapeutics Insider Sells 21,000 Shares for $166,700 After 65% Run
📊
AI Sentiment
Positive
6/10
Share this news page